MedTrace Logo

Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)

NCT03136458 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-10-11

No results posted yet for this study

Summary

This study evaluates remote ischemic preconditioning as an strategy to avoid contrast induced nephropathy. All of the patients will receive endovenous normal saline to prevent nephropathy, half of the patients will receive remote ischemic preconditioning while the other half will not.

Conditions

  • Contrast-induced Nephropathy

Interventions

PROCEDURE

Ischemic preconditioning

Repeated remote ischemic preconditioning by arterial cuff insufflation.

DRUG

Endovenous normal saline

endovenous normal saline 1 mL per Kg per hour before and after contrast media injection.

Sponsors & Collaborators

  • Camilo Andrés Páez Angarita

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-10-09
Completion
2018-10-09

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03136458 on ClinicalTrials.gov